Auréa Group, the owner of The Body Shop has recently invested in Zenagen and ACT/IV, two leading hair care brands. The main idea behind this initiative is to diversify its portfolio of beauty and personal care brands after it acquired The Body Shop in 2024. It has invested an undisclosed sum into Nutraceutical Research Innovations (NRI), the US-based holding company for Zenagen and ACT/IV.
Paul Raphae, Auréa’s CEO stated that both Zenagen and ACT/IV are known for delivering result-oriented solutions. Besides an increasing demand from consumers for high-end, result-oriented products, Nutraceutical Research Innovations (NRI) would do exceptionally well. The partnership will gain from Auréa’s operational experience and networking and help the brands expand.
Also Read: Samantha Kochharr Appointed as The First Asian Chief Expert for Hair at World Skills Competition
Auréa plans to leverage its operational expertise and extensive network to accelerate the growth of both brands. The firm aims to strengthen Zenagen’s position in the professional market while also exploring direct-to-consumer channels like Amazon. For ACT/IV, Auréa will prioritize digital growth and seek opportunities for further retail expansion.
Zenagen, founded in 2008, is a professional haircare brand offering plant-based products designed to address hair thinning and promote healthy hair growth. Its products are sold through salons, spas, dermatology clinics, and aesthetic therapists. ACT/IV, established in 2016, is a lifestyle haircare brand with a strong presence in professional beauty channels.
Also Read: HUL in Advanced Talks To Acquire Minimalist
This investment reflects Auréa’s strategy of identifying and supporting high-potential brands in the beauty and wellness industry. The firm’s acquisition of The Body Shop last year demonstrated its ambition to build a portfolio of purpose-driven brands that resonate with consumers. With its investment in Zenagen and ACT/IV, Auréa is further solidifying its position as a key player in the haircare market.